Literature DB >> 10768980

Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.

E N Villegas1, U Wille, L Craig, P S Linsley, D M Rennick, R Peach, C A Hunter.   

Abstract

Interleukin-10 (IL-10) is associated with inhibition of cell-mediated immunity and downregulation of the expression of costimulatory molecules required for T-cell activation. When IL-10-deficient (IL-10KO) mice are infected with Toxoplasma gondii, they succumb to a T-cell-mediated shock-like reaction characterized by the overproduction of IL-12 and gamma interferon (IFN-gamma) associated with widespread necrosis of the liver. Since costimulation is critical for T-cell activation, we investigated the role of the CD28-B7 and CD40-CD40 ligand (CD40L) interactions in this infection-induced immunopathology. Our studies show that infection of mice with T. gondii resulted in increased expression of B7 and CD40 that was similar in wild-type and IL-10KO mice. In vivo blockade of the CD28-B7 or CD40-CD40L interactions following infection of IL-10KO mice with T. gondii did not affect serum levels of IFN-gamma or IL-12, nor did it prevent death in these mice. However, when both pathways were blocked, the IL-10KO mice survived the acute phase of infection and had reduced serum levels of IFN-gamma and alanine transaminase as well as decreased expression of inducible nitric oxide synthase in the liver and spleen. Analysis of parasite-specific recall responses from infected IL-10KO mice revealed that blockade of the CD40-CD40L interaction had minimal effects on cytokine production, whereas blockade of the CD28-B7 interaction resulted in decreased production of IFN-gamma but not IL-12. Further reduction of IFN-gamma production was observed when both costimulatory pathways were blocked. Together, these results demonstrate that the CD28-B7 and CD40-CD40L interactions are involved in the development of infection-induced immunopathology in the absence of IL-10.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768980      PMCID: PMC97495          DOI: 10.1128/IAI.68.5.2837-2844.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra; H Ishida; R de Waal Malefyt; J de Vries
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

2.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

Authors:  R T Gazzinelli; I P Oswald; S L James; A Sher
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

3.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

4.  The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.

Authors:  G Reichmann; W Walker; E N Villegas; L Craig; G Cai; J Alexander; C A Hunter
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  B7/CD28-dependent and -independent induction of CD40 ligand expression.

Authors:  L Ding; J M Green; C B Thompson; E M Shevach
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

6.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

Review 7.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

10.  Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype.

Authors:  V Brinkmann; S D Sharma; J S Remington
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

View more
  13 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 2.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.

Authors:  Emily S Cribas; Joshua E Denny; Jeffrey R Maslanka; Michael C Abt
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

4.  B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses.

Authors:  Emma H Wilson; Colby Zaph; Markus Mohrs; Andy Welcher; Jerry Siu; David Artis; Christopher A Hunter
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

5.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Diverse roles for T-bet in the effector responses required for resistance to infection.

Authors:  Gretchen Harms Pritchard; Aisling O'Hara Hall; David A Christian; Sagie Wagage; Qun Fang; Gaia Muallem; Beena John; Arielle Glatman Zaretsky; William G Dunn; Jacqueline Perrigoue; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2015-01-02       Impact factor: 5.422

7.  Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection.

Authors:  A R Hayward; M Cosyns; M Jones; E M Ponnuraj
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 8.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

9.  Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice.

Authors:  Lili Chen; Wen Cheng; Pooja Shivshankar; Lei Lei; Xiaoyun Zhang; Yimou Wu; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

10.  Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Rodrigo T Figueiredo; Marcelo T Bozza; Flávia R S Lima; Ana Lúcia Pires; Patrícia M Silva; Adriana Bonomo; Joseli Lannes-Vieira; Wanderley De Souza; Vivaldo Moura-Neto
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.